james-brey / iStockphoto.com

15 September 2017Americas

Dow asks SCOTUS to review $445m award dispute

Agriculture company Dow has asked the US Supreme Court to review a dispute centring on damages for infringement of patents related to genetically engineered soybeans.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

AstraZeneca opposes Mylan’s request for SCOTUS hearing

25 November 2016 AstraZeneca and Acorda have asked the US Supreme Court not to hear an appeal from Mylan challenging a Federal Circuit ruling.

Biosimilars Council urges SCOTUS to limit biologics exclusivity period

22 February 2017 The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), has filed a brief in support of Sandoz’s petition for certiorari in the pending Sandoz v Amgen case.

SCOTUS rejects Dow’s $455m appeal against Bayer

5 December 2017 The US Supreme Court has refused to rule on a patent dispute between agricultural companies Dow AgroSciences and Bayer CropScience.

More on this story

AstraZeneca opposes Mylan’s request for SCOTUS hearing

25 November 2016 AstraZeneca and Acorda have asked the US Supreme Court not to hear an appeal from Mylan challenging a Federal Circuit ruling.

Biosimilars Council urges SCOTUS to limit biologics exclusivity period

22 February 2017 The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), has filed a brief in support of Sandoz’s petition for certiorari in the pending Sandoz v Amgen case.

SCOTUS rejects Dow’s $455m appeal against Bayer

5 December 2017 The US Supreme Court has refused to rule on a patent dispute between agricultural companies Dow AgroSciences and Bayer CropScience.

More on this story

AstraZeneca opposes Mylan’s request for SCOTUS hearing

25 November 2016 AstraZeneca and Acorda have asked the US Supreme Court not to hear an appeal from Mylan challenging a Federal Circuit ruling.

Biosimilars Council urges SCOTUS to limit biologics exclusivity period

22 February 2017 The Biosimilars Council, a division of the Association for Accessible Medicines (AAM), has filed a brief in support of Sandoz’s petition for certiorari in the pending Sandoz v Amgen case.

SCOTUS rejects Dow’s $455m appeal against Bayer

5 December 2017 The US Supreme Court has refused to rule on a patent dispute between agricultural companies Dow AgroSciences and Bayer CropScience.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB

Lewis Roca promotes tech expert to managing partner

Panitch Schwarze brings in molecular biologist

US targets ‘product hopping’ with biologic litigation curbs

UPC confirms validity of Edwards Lifesciences heart valve tech patent

ITC concludes row over biotech lab equipment between US and German rivals

UKIPO launches ‘revolutionary’ patent filing and AI tool

USPTO clarifies AI's role in patent eligibility